NMUR1

Summary

NMUR1 (neuromedin U receptor 1, HGNC:4518) is a protein-coding gene on chromosome 2q37.1, encoding Neuromedin-U receptor 1 (Q9HB89). Receptor for the neuromedin-U and neuromedin-S neuropeptides.

Enables neuromedin U binding activity and neuromedin U receptor activity. Involved in several processes, including calcium-mediated signaling; chloride transport; and positive regulation of calcium-mediated signaling. Located in membrane.

Source: NCBI Gene 10316 — RefSeq curated summary.

At a glance

• GWAS associations: 2
• Clinical variants (ClinVar): 100 total
• Druggable target: yes
• MANE Select transcript: NM_006056

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:4518
Approved symbol	NMUR1
Name	neuromedin U receptor 1
Location	2q37.1
Locus type	gene with protein product
Status	Approved
Aliases	GPC-R, FM-3, NMU1R
Ensembl gene	ENSG00000171596
Ensembl biotype	protein_coding
OMIM	604153
Entrez	10316

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000305141

RefSeq mRNA: 1 — MANE Select: NM_006056 NM_006056

CCDS: CCDS2486

Canonical transcript exons

ENST00000305141 — 3 exons

Exon	Start	End
ENSE00001146749	231528123	231529017
ENSE00001276860	231523187	231525425
ENSE00001348103	231530359	231530445

Expression profiles

Bgee: expression breadth ubiquitous, 144 present calls, max score 88.49.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5416 / max 85.9031, expressed in 136 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter ID	TPM avg	Samples expressed
34527	0.4632	129
34528	0.0496	26
34526	0.0288	12

Top tissues by expression

255 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
granulocyte	CL:0000094	88.49	gold quality
primordial germ cell in gonad	CL:0000670 ∩ UBERON:0000991	79.69	gold quality
tendon of biceps brachii	UBERON:0008188	76.84	gold quality
buccal mucosa cell	CL:0002336	74.63	gold quality
male germ line stem cell (sensu Vertebrata) in testis	CL:0000089 ∩ UBERON:0000473	73.15	gold quality
blood	UBERON:0000178	68.40	gold quality
parotid gland	UBERON:0001831	67.78	gold quality
myocardium	UBERON:0002349	67.70	gold quality
right lung	UBERON:0002167	67.59	gold quality
body of pancreas	UBERON:0001150	67.48	gold quality
esophagogastric junction muscularis propria	UBERON:0035841	67.44	gold quality
spleen	UBERON:0002106	67.33	gold quality
subcutaneous adipose tissue	UBERON:0002190	66.47	gold quality
lower esophagus	UBERON:0013473	65.99	gold quality
lower esophagus muscularis layer	UBERON:0035833	65.97	gold quality
leukocyte	CL:0000738	65.53	gold quality
adipose tissue	UBERON:0001013	64.04	gold quality
monocyte	CL:0000576	63.96	gold quality
omental fat pad	UBERON:0010414	63.95	gold quality
peritoneum	UBERON:0002358	63.89	gold quality
adipose tissue of abdominal region	UBERON:0007808	63.62	gold quality
medial globus pallidus	UBERON:0002477	63.56	gold quality
right uterine tube	UBERON:0001302	63.36	gold quality
upper lobe of left lung	UBERON:0008952	63.15	gold quality
small intestine Peyer’s patch	UBERON:0003454	62.48	gold quality
oviduct epithelium	UBERON:0004804	62.10	silver quality
small intestine	UBERON:0002108	61.74	gold quality
upper lobe of lung	UBERON:0008948	61.39	gold quality
cartilage tissue	UBERON:0002418	61.24	gold quality
mucosa of transverse colon	UBERON:0004991	60.92	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	5.63

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

74 targeting NMUR1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-4283	100.00	66.42	2097
HSA-MIR-4795-3P	100.00	74.62	4024
HSA-MIR-3924	100.00	72.09	2394
HSA-MIR-4747-5P	100.00	67.90	2681
HSA-MIR-5196-5P	100.00	67.98	2761
HSA-MIR-4789-3P	99.99	70.75	2484
HSA-MIR-34A-5P	99.99	71.21	1784
HSA-MIR-449A	99.99	71.05	1776
HSA-MIR-6870-5P	99.99	68.55	2115
HSA-MIR-4803	99.98	71.99	3117
HSA-MIR-4775	99.98	75.00	6394
HSA-MIR-5698	99.97	68.49	2029
HSA-MIR-34C-5P	99.97	70.45	1577
HSA-MIR-449B-5P	99.97	70.26	1580
HSA-MIR-4723-5P	99.97	68.70	2034
HSA-MIR-7111-5P	99.97	68.48	2062
HSA-MIR-6825-5P	99.96	69.81	3431
HSA-MIR-548AT-5P	99.96	70.83	2666
HSA-MIR-4267	99.96	66.53	2368
HSA-MIR-335-3P	99.93	73.36	4958
HSA-MIR-153-5P	99.89	73.86	6317
HSA-MIR-4731-5P	99.89	67.23	2537
HSA-MIR-4302	99.89	67.94	1187
HSA-MIR-7162-3P	99.89	68.16	1682
HSA-MIR-605-3P	99.88	69.22	1833
HSA-MIR-3941	99.86	70.54	2735
HSA-MIR-4760-5P	99.80	69.88	1619
HSA-MIR-6885-3P	99.75	70.36	3187
HSA-MIR-10393-3P	99.72	66.56	961
HSA-MIR-6801-5P	99.72	66.50	981

Literature-anchored findings (GeneRIF, showing 3)

• Increased NMUR1 Expression in Mast Cells in the Synovial Membrane of Obese Osteoarthritis Patients. (PMID:36232539)
• Neuromedin U regulates the anti-tumor activity of CD8[+] T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1-dependent manner. (PMID:38071753)
• Expression of NMU and NMUR1 in tryptase-positive mast cells and PBLs in allergic rhinitis patients’ nasal mucosa. (PMID:38378005)

Cross-species orthologs

11 orthologs

Organism	Symbol	Gene ID
danio_rerio	nmur1b	ENSDARG00000003944
danio_rerio	nmur3	ENSDARG00000022570
danio_rerio	nmur1a	ENSDARG00000060884
mus_musculus	Nmur1	ENSMUSG00000026237
rattus_norvegicus	Nmur1	ENSRNOG00000018521
drosophila_melanogaster	CapaR	FBGN0037100
drosophila_melanogaster	PK2-R2	FBGN0038139
drosophila_melanogaster	PK2-R1	FBGN0038140
drosophila_melanogaster	PK1-R	FBGN0038201
caenorhabditis_elegans		WBGENE00016747
caenorhabditis_elegans		WBGENE00019616

Paralogs (15): NTSR1 (ENSG00000101188), BRS3 (ENSG00000102239), MLNR (ENSG00000102539), GHSR (ENSG00000121853), GRPR (ENSG00000126010), NMUR2 (ENSG00000132911), NMBR (ENSG00000135577), EDNRB (ENSG00000136160), EDNRA (ENSG00000151617), NTSR2 (ENSG00000169006), GPR37L1 (ENSG00000170075), GPR37 (ENSG00000170775), GPR148 (ENSG00000173302), TRHR (ENSG00000174417), GPR39 (ENSG00000183840)

Protein

Protein identifiers

Neuromedin-U receptor 1 — Q9HB89 (reviewed: Q9HB89)

Alternative names: G-protein coupled receptor 66, G-protein coupled receptor FM-3

All UniProt accessions (1): Q9HB89

UniProt curated annotations — full annotation on UniProt →

Function. Receptor for the neuromedin-U and neuromedin-S neuropeptides.

Subcellular location. Cell membrane.

Tissue specificity. Expressed in greatest abundance in peripheral organs, particularly in elements of the gastrointestinal and urogenital systems with highest levels in testes. In central nervous system structures express levels are much lower than those seen in peripheral organs. Within the CNS, has been detected in highest abundance in the cerebellum, dorsal root ganglia, hippocampus, and spinal cord.

Similarity. Belongs to the G-protein coupled receptor 1 family.

RefSeq proteins (1): NP_006047* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR000276	GPCR_Rhodpsn	Family
IPR005390	NeuromedU_rcpt	Family
IPR005391	NeuromedU_rcpt_1	Family
IPR017452	GPCR_Rhodpsn_7TM	Domain

Pfam: PF00001

UniProt features (36 total): helix 12, topological domain 8, transmembrane region 7, glycosylation site 3, strand 2, chain 1, disulfide bond 1, sequence conflict 1, turn 1

Structure

Experimental structures (PDB)

2 structures.

PDB	Method	Resolution (Å)
7W56	ELECTRON MICROSCOPY	2.9
7W53	ELECTRON MICROSCOPY	3.2

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q9HB89-F1	81.23	0.58

Antibody-complex structures (SAbDab): 2 — 7W53, 7W56

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (1): 134–219

Glycosylation sites (3): 7, 27, 41

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

ID	Pathway
R-HSA-375276	Peptide ligand-binding receptors
R-HSA-416476	G alpha (q) signalling events
R-HSA-418594	G alpha (i) signalling events

MSigDB gene sets: 99 (showing top): GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING, GOBP_INORGANIC_ANION_TRANSPORT, REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS, GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING, GOBP_CHLORIDE_TRANSPORT, GOBP_MUSCLE_CONTRACTION, KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION, GOBP_SMOOTH_MUSCLE_CONTRACTION, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOMF_PEPTIDE_RECEPTOR_ACTIVITY, MYB_Q3, GOBP_MUSCLE_SYSTEM_PROCESS, GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, MYB_Q5_01, GOCC_CILIUM

GO Biological Process (8): chloride transport (GO:0006821), smooth muscle contraction (GO:0006939), G protein-coupled receptor signaling pathway (GO:0007186), phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200), neuropeptide signaling pathway (GO:0007218), calcium-mediated signaling (GO:0019722), positive regulation of calcium-mediated signaling (GO:0050850), signal transduction (GO:0007165)

GO Molecular Function (4): neuromedin U receptor activity (GO:0001607), G protein-coupled receptor activity (GO:0004930), neuropeptide receptor activity (GO:0008188), neuromedin U binding (GO:0042924)

GO Cellular Component (3): plasma membrane (GO:0005886), cilium (GO:0005929), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

Category	Pathways
GPCR downstream signalling	2
Class A/1 (Rhodopsin-like receptors)	1

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
G protein-coupled receptor signaling pathway	3
neuropeptide binding	2
monoatomic anion transport	1
inorganic anion transport	1
muscle contraction	1
G protein-coupled receptor activity	1
signal transduction	1
phospholipase C activator activity	1
intracellular signaling cassette	1
calcium-mediated signaling	1
regulation of calcium-mediated signaling	1
positive regulation of intracellular signal transduction	1
cell communication	1
cellular process	1
signaling	1
regulation of cellular process	1
cellular response to stimulus	1
neuropeptide receptor activity	1
neuromedin U binding	1
transmembrane signaling receptor activity	1
neuropeptide signaling pathway	1
G protein-coupled peptide receptor activity	1
membrane	1
cell periphery	1
intraciliary transport particle	1
membrane-bounded organelle	1
plasma membrane bounded cell projection	1
cellular anatomical structure	1

Protein interactions and networks

STRING

832 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
NMUR1	NMU	P48645	999
NMUR1	NMS	Q5H8A3	972
NMUR1	GNAQ	P50148	520
NMUR1	FSHB	P01225	509
NMUR1	GPR55	Q9Y2T6	440
NMUR1	GNAO1	P09471	435
NMUR1	FBXO8	Q9NRD0	435
NMUR1	POMC	P01189	430
NMUR1	CRHR1	P34998	423
NMUR1	VIPR2	P41587	421
NMUR1	IL33	O95760	418
NMUR1	GPR157	Q5UAW9	418
NMUR1	IL1B	P01584	414
NMUR1	GABRG1	Q8N1C3	410
NMUR1	GALR2	O43603	410
NMUR1	DRD5	P21918	410

IntAct

0 interactions, top by confidence:

BioGRID (3): NMU (Reconstituted Complex), NMUR1 (Reconstituted Complex), NMUR1 (Reconstituted Complex)

ESM2 similar proteins: A0A2R9YJI3, B2ZHY2, B4XF06, D4A3U0, O43194, O55040, O88319, O95136, P0C0W8, P11617, P20272, P20789, P21554, P29274, P30543, P32940, P34972, P34979, P46616, P47746, P47752, P47936, P49684, P50129, P51810, P52592, P70259, Q58CW4, Q5IS73, Q5U431, Q60613, Q6DWJ6, Q6TLI7, Q71SP5, Q75Z89, Q7TQN9, Q80UC8, Q8BGE9, Q8BZ39, Q8BZL4

Diamond homologs: A1ZAX0, B2ZI34, E7F7V7, F1MV99, F1R332, O08726, O08786, O43603, O54798, O54799, O62709, O88626, O88854, O97666, O97772, O97967, P05363, P08911, P08912, P21451, P21729, P22270, P24053, P24530, P25101, P26684, P28088, P28336, P28646, P30550, P30551, P30552, P30553, P30796, P30872, P30873, P30937, P30974, P31391, P32238

SIGNOR signaling

4 interactions.

A	Effect	B	Mechanism
NMS	up-regulates	NMUR1	binding
NMUR1	“up-regulates activity”	GNAQ	binding
NMUR1	“up-regulates activity”	GNA14	binding
VXJPSOQJNUZHDN-YJFQKBDPSA-N	“up-regulates activity”	NMUR1	“chemical activation”

Disease & clinical

Clinical variants and AI predictions

ClinVar

100 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	80
Likely benign	10
Benign	4

Top pathogenic / likely-pathogenic (0)

SpliceAI

697 predictions. Top by Δscore:

Variant	Effect	Δscore
2:231527137:A:AC	donor_gain	1.0000
2:231527138:C:CC	donor_gain	1.0000
2:231528116:CACTT:C	donor_loss	1.0000
2:231528117:ACTTA:A	donor_loss	1.0000
2:231528120:TA:T	donor_loss	1.0000
2:231528121:A:AC	donor_gain	1.0000
2:231528121:A:AT	donor_loss	1.0000
2:231528122:C:CC	donor_gain	1.0000
2:231528122:CA:C	donor_gain	1.0000
2:231528122:CACA:C	donor_gain	1.0000
2:231528122:CACAG:C	donor_gain	1.0000
2:231525421:GACAA:G	acceptor_gain	0.9900
2:231525423:CAA:C	acceptor_gain	0.9900
2:231525426:C:CC	acceptor_gain	0.9900
2:231527250:T:C	donor_gain	0.9900
2:231528120:TAC:T	donor_gain	0.9900
2:231528121:ACA:A	donor_gain	0.9900
2:231528122:CAC:C	donor_gain	0.9900
2:231529018:C:CC	acceptor_gain	0.9900
2:231530355:CTA:C	donor_loss	0.9900
2:231530356:TA:T	donor_loss	0.9900
2:231525422:ACAA:A	acceptor_gain	0.9800
2:231525423:CAAC:C	acceptor_gain	0.9800
2:231525424:AA:A	acceptor_gain	0.9800
2:231525424:AACTG:A	acceptor_loss	0.9800
2:231525425:ACT:A	acceptor_loss	0.9800
2:231525426:C:A	acceptor_loss	0.9800
2:231525427:T:A	acceptor_loss	0.9800
2:231528119:TTA:T	donor_gain	0.9800
2:231529013:GGAGT:G	acceptor_gain	0.9800

AlphaMissense

2743 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
2:231528718:G:C	S101R	0.994
2:231528718:G:T	S101R	0.994
2:231528720:T:G	S101R	0.994
2:231528553:G:C	S156R	0.987
2:231528553:G:T	S156R	0.987
2:231528555:T:G	S156R	0.987
2:231528277:G:C	S248R	0.981
2:231528277:G:T	S248R	0.981
2:231528279:T:G	S248R	0.981
2:231525406:A:C	F306L	0.972
2:231525406:A:T	F306L	0.972
2:231525408:A:G	F306L	0.972
2:231528640:G:C	F127L	0.966
2:231528640:G:T	F127L	0.966
2:231528642:A:G	F127L	0.966
2:231525235:G:C	F363L	0.965
2:231525235:G:T	F363L	0.965
2:231525237:A:G	F363L	0.965
2:231528465:A:G	W186R	0.963
2:231528465:A:T	W186R	0.963
2:231528620:C:G	C134S	0.962
2:231528621:A:T	C134S	0.962
2:231525385:G:C	F313L	0.961
2:231525385:G:T	F313L	0.961
2:231525387:A:G	F313L	0.961
2:231525374:C:G	R317P	0.956
2:231528777:A:G	C82R	0.950
2:231528365:C:G	C219S	0.948
2:231528366:A:T	C219S	0.948
2:231528596:T:A	E142V	0.946

dbSNP variants (sampled 300 via entrez): RS1000290657 (2:231527987 C>T), RS1000306403 (2:231522068 C>T), RS1000583643 (2:231527623 G>C), RS1000640571 (2:231523700 C>G,T), RS1000691403 (2:231523307 A>G), RS1001065161 (2:231527166 C>T), RS1001249969 (2:231521464 G>T), RS1001344582 (2:231520295 G>A), RS1001435941 (2:231520612 G>A), RS1001924521 (2:231522341 G>A), RS1001970019 (2:231518050 G>A), RS1002374286 (2:231524472 T>G), RS1002440363 (2:231522044 A>G), RS1003014965 (2:231529340 A>T), RS1003350435 (2:231530835 C>A)

Disease associations

OMIM: gene MIM:604153 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

Study	Trait	p-value
GCST001859_46	Thiazide-induced adverse metabolic effects in hypertensive patients	4.000000e-06
GCST007159_1	Corneal astigmatism	2.000000e-06

EFO canonical traits (1, from GWAS)

EFO ID	Trait name
EFO:1002040	Corneal astigmatism

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL1075178 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Neuromedin U receptors

Most potent curated ligand interactions (16 total), top 16:

Ligand	Action	Affinity	Parameter
neuromedin U-23	Agonist	10.1	pKi
[125I]neuromedin U-25 (human)	Agonist	10.1	pKd
compound 5d [PMID: 25815150]	Full agonist	10.08	pEC50
neuromedin S-33	Agonist	10.0	pIC50
CPN-267	Agonist	9.6	pEC50
neuromedin U-25	Agonist	9.6	pKi
neuromedin U-25	Agonist	9.5	pKi
[125I]neuromedin U-23 (rat)	Agonist	9.5	pKd
HAS-NMU	Full agonist	9.0	pEC50
compound 8d [PMID: 24999562]	Full agonist	9.0	pEC50
neuromedin U-8	Agonist	8.8	pKi
[125I]neuromedin U-8 (pig)	Agonist	8.6	pKd
neuromedin U-8	Agonist	8.5	pKi
CPN-223	Partial agonist	8.49	pEC50
PEG40-NMU	Full agonist	8.0	pEC50
NM4-C16	Full agonist	6.3	pEC50

ChEMBL bioactivities

164 potent at pChembl≥5 of 166 total, top 50 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChembl	Type	Value	Unit	Molecule
10.43	IC50	0.037	nM	CHEMBL4174679
10.08	EC50	0.083	nM	CHEMBL3425593
10.07	IC50	0.086	nM	CHEMBL4165538
10.04	IC50	0.092	nM	CHEMBL4162728
9.85	EC50	0.14	nM	CHEMBL3315349
9.82	IC50	0.15	nM	CHEMBL4177021
9.77	EC50	0.17	nM	CHEMBL4069151
9.60	EC50	0.25	nM	CHEMBL4105671
9.54	IC50	0.29	nM	CHEMBL4169726
9.51	EC50	0.31	nM	CHEMBL4098010
9.51	IC50	0.31	nM	CHEMBL4160825
9.49	EC50	0.32	nM	CHEMBL4068681
9.49	IC50	0.32	nM	CHEMBL4175546
9.47	IC50	0.34	nM	CHEMBL4172552
9.44	IC50	0.36	nM	CHEMBL4164922
9.39	EC50	0.41	nM	CHEMBL4088263
9.39	IC50	0.41	nM	CHEMBL4165337
9.37	EC50	0.43	nM	CHEMBL3315349
9.35	EC50	0.45	nM	CHEMBL3356083
9.29	EC50	0.51	nM	CHEMBL4169726
9.29	IC50	0.51	nM	CHEMBL4175953
9.27	EC50	0.54	nM	CHEMBL3356083
9.27	IC50	0.54	nM	CHEMBL4170275
9.25	EC50	0.5623	nM	CHEMBL3758577
9.24	EC50	0.5754	nM	CHEMBL3759452
9.14	EC50	0.73	nM	CHEMBL4059530
9.12	IC50	0.75	nM	CHEMBL4159554
9.11	EC50	0.77	nM	CHEMBL4073946
9.11	IC50	0.78	nM	CHEMBL3356083
9.06	IC50	0.88	nM	CHEMBL4161902
9.02	EC50	0.96	nM	CHEMBL4095998
9.01	IC50	0.97	nM	CHEMBL4164026
9.00	EC50	1	nM	CHEMBL4079986
8.97	EC50	1.072	nM	CHEMBL3315349
8.92	IC50	1.2	nM	CHEMBL4168753
8.89	EC50	1.3	nM	CHEMBL4063830
8.80	EC50	1.6	nM	CHEMBL4161902
8.80	IC50	1.6	nM	CHEMBL4167677
8.77	EC50	1.7	nM	CHEMBL3315348
8.75	EC50	1.778	nM	CHEMBL4299242
8.72	EC50	1.9	nM	CHEMBL4087867
8.66	EC50	2.2	nM	CHEMBL3315348
8.66	EC50	2.2	nM	CHEMBL4061507
8.62	IC50	2.4	nM	CHEMBL4173224
8.57	EC50	2.7	nM	CHEMBL4089636
8.57	EC50	2.7	nM	CHEMBL4099780
8.54	EC50	2.9	nM	CHEMBL4162728
8.52	IC50	3	nM	CHEMBL4164987
8.49	EC50	3.2	nM	CHEMBL4798983
8.43	EC50	3.7	nM	CHEMBL4170275

PubChem BioAssay actives

168 with measured affinity, of 413 total; 50 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

Compound	Assay	Type	Value	Unit
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S)-2-acetyl-7-hydroxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	<0.0001	uM
(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-3-(4-fluorophenyl)-2-[[(2S)-3-(1H-indol-3-yl)-2-[(2-thiophen-2-ylacetyl)amino]propanoyl]amino]propanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]butanediamide	1205844: Agonist activity at human NMUR1 expressed in CHO cells assessed as intracellular calcium flux at by Fluo-4 AM dye based fluorometric imaging method	ec50	0.0001	uM
(4S)-5-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[(2S)-2-[[(2S)-5-carbamimidamido-1-[[(2S)-1,4-diamino-1,4-dioxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoic acid	1205844: Agonist activity at human NMUR1 expressed in CHO cells assessed as intracellular calcium flux at by Fluo-4 AM dye based fluorometric imaging method	ec50	0.0001	uM
(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carbonyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0001	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S)-2-acetyl-7-hydroxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1355076: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cells after 3 hrs by topcount micro scintillation counting method	ic50	0.0001	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0001	uM
(4R)-5-[[(2R)-1-[[(2R)-5-amino-1-[[(2R)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[(2S)-2-[[(2S)-5-carbamimidamido-1-[[(2S)-1,4-diamino-1,4-dioxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoic acid	1448849: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux after 18 hrs by Fluo-4 AM dye based FLIPR assay	ec50	0.0002	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0003	uM
(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(4-hydroxyphenyl)-2-[(2-piperazin-1-ylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0003	uM
(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-3-(1H-indol-3-yl)-2-[(2-thiophen-2-ylacetyl)amino]propanoyl]amino]-2-methylpropanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoic acid	1448849: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux after 18 hrs by Fluo-4 AM dye based FLIPR assay	ec50	0.0003	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0003	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0003	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-naphthalen-1-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0003	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0003	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1464656: Agonist activity at human NMUR1 expressed in CHO cells assessed as increase in intracellular calcium influx after 180 secs by Fluo 4-AM dye based FLIPR assay	ec50	0.0004	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0004	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0004	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-naphthalen-1-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0004	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1355076: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cells after 3 hrs by topcount micro scintillation counting method	ic50	0.0005	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0005	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1273137: Agonist activity at recombinant human NMU1 expressed in HEK293 cells assessed as change in intracellular calcium flux by fluorescence assay	ec50	0.0006	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1273137: Agonist activity at recombinant human NMU1 expressed in HEK293 cells assessed as change in intracellular calcium flux by fluorescence assay	ec50	0.0006	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-pyridin-4-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0007	uM
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0008	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-N’-benzylbutanediamide	1355076: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cells after 3 hrs by topcount micro scintillation counting method	ic50	0.0008	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0009	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0010	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0010	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0010	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(3S)-2-[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]-7-hydroxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0012	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-cyclohexylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0013	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0016	uM
(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-naphthalen-2-yl-2-(3-pyridin-3-ylpropanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]butanediamide	1721615: Partial agonist activity at human NMUR1 expressed in CHO cells by calcium mobilization assay	ec50	0.0017	uM
(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[2-[3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(hexadecanoylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2-methylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]butanediamide	1273137: Agonist activity at recombinant human NMU1 expressed in HEK293 cells assessed as change in intracellular calcium flux by fluorescence assay	ec50	0.0018	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0019	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-cyclohexyl-2-[[(2S)-3-(4-hydroxyphenyl)-2-[(2-piperazin-1-ylacetyl)amino]propanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0022	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S)-2-acetyl-7-hydroxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-aminopropanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1355076: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cells after 3 hrs by topcount micro scintillation counting method	ic50	0.0024	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-cyclohexylpropanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0027	uM
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(6-aminohexanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-methylamino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0027	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S)-2-acetyl-7-hydroxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]-methylamino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1355076: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cells after 3 hrs by topcount micro scintillation counting method	ic50	0.0030	uM
(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-naphthalen-2-yl-2-(3-pyridin-3-ylpropanoylamino)propanoyl]amino]-3-(4-phenylphenyl)propanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]butanediamide	1721603: Agonist activity at human NMUR1 expressed in CHO cells by calcium mobilization assay	ec50	0.0032	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]-[2-(4-hydroxyphenyl)ethyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0039	uM
(2S)-5-[3-[2-[2-[3-[[2-[2-[[(2S)-1-[[1-[[(2S)-1-[[1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethoxy]acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-2-[[4-[(octadecanoylamino)methyl]cyclohexanecarbonyl]amino]-5-oxopentanoic acid	1464656: Agonist activity at human NMUR1 expressed in CHO cells assessed as increase in intracellular calcium influx after 180 secs by Fluo 4-AM dye based FLIPR assay	ec50	0.0063	uM
(2S)-N-[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-3-(4-fluorophenyl)-2-[[(2S)-3-(1H-indol-3-yl)-2-[methyl-(2-thiophen-2-ylacetyl)amino]propanoyl]amino]propanoyl]amino]pentanoyl]pyrrolidine-2-carboxamide	2094911: Antagonist potency at human NMUR1 stably expressed in CHO cells by Fluo-4 AM dye based calcium mobilization assay	kd	0.0065	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0078	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(3-aminopropanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-cyclohexylpropanoyl]amino]-4-methylpentanoyl]amino]-3-pyridin-4-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1446043: Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	ec50	0.0081	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352032: Agonist activity at human NMUR1 expressed in HEK293 cells assessed as induction of IP3 levels using myo-[2-3H(N)]-inositol after 60 mins by SPA-based topcount assay	ec50	0.0081	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-N’-methylbutanediamide	1355076: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cells after 3 hrs by topcount micro scintillation counting method	ic50	0.0082	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(3S)-2-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]-7-hydroxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1352038: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cell membranes after 3 hrs by microscintillation counting	ic50	0.0086	uM
(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3,4-dihydro-1H-naphthalene-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide	1355076: Displacement of [3H]-NMU-8 from human NMUR1 expressed in HEK293 cells after 3 hrs by topcount micro scintillation counting method	ic50	0.0088	uM

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Tetrachlorodibenzodioxin	decreases expression, increases expression	2
GSK-J4	decreases expression	1
triphenyl phosphate	affects expression	1
propionaldehyde	increases expression	1
quercitrin	decreases expression	1
butyraldehyde	increases expression	1
S-(1,2-dichlorovinyl)cysteine	affects cotreatment, decreases expression, affects response to substance, increases expression	1
pentanal	increases expression	1
di-n-butylphosphoric acid	affects expression	1
aseanostatin P5	affects binding, increases activity	1
CGP 52608	affects binding, increases reaction	1
Acetaminophen	increases expression	1
Air Pollutants	increases abundance, increases expression	1
Aldehydes	increases expression	1
Benzo(a)pyrene	affects methylation	1
Lead	affects methylation	1
Lipopolysaccharides	decreases expression, affects response to substance, increases expression, affects cotreatment	1
Valproic Acid	increases methylation	1
Particulate Matter	increases abundance, increases expression	1

ChEMBL screening assays

48 unique, capped per target: 32 functional, 9 binding, 7 admet

Representative assays (with source publication via chembl_document):

Assay ID	Type	Description	Source paper
CHEMBL1107818	Binding	Binding affinity to NMUR1	Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach. — Eur J Med Chem
CHEMBL3362244	Functional	Agonist activity at human NMUR1 expressed in HEK293 cells at 1 to 100 nM by calcium mobilization assay relative to NMU	Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2. — J Med Chem
CHEMBL4013732	ADMET	Agonist activity at human NMUR1 expressed in CHO cells assessed as induction of Ca2+ flux measured for 180 secs by Fluo 4-AM dye-based FLIPR assay	Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide. — J Med Chem

Cellosaurus cell lines

4 cell lines: 2 spontaneously immortalized cell line, 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_H473	CHO-K1/NMU1	Spontaneously immortalized cell line	Female
CVCL_LA89	PathHunter U2OS NMU1R beta-arrestin	Cancer cell line	Female
CVCL_LA90	PathHunter U2OS NMU1R Total GPCR Internalization	Cancer cell line	Female
CVCL_ZK64	GeneBLAzer NMUR1-NFAT-bla CHO-K1	Spontaneously immortalized cell line	Female

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.